Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mapp Biopharmaceutical Inc.

www.mappbio.com

Latest From Mapp Biopharmaceutical Inc.

Neurology At The Forefront Of US FDA Complex Innovative Trial Design Pilot

Wave’s Duchenne muscular dystrophy drug crashed, but Lilly’s chronic pain R&D will test the agency’s CID meeting pilot program, while FDA issues draft guidance that highlights potential uses for complex innovative trial designs.

Clinical Trials Neurology

Vir Advances Antibodies Against COVID-19, CEO Scangos Leads BIO’s Coronavirus Outreach

Scrip talked to George Scangos about his dual roles in the pandemic response, helming Vir as the company tests antibody and siRNA approaches while working with BIO to facilitate coronavirus collaborations.

Coronavirus COVID-19 Business Strategies

COVID-19 Study Of Gilead’s Remdesivir Using Ebola-Style Adaptive Platform Trial

First COVID-19 experimental treatment trial in US is a master protocol that echoes NIH’s Ebola treatment approach.

Coronavirus COVID-19 Vaccines

Keeping Track: US FDA Approvals For Ibsrela, Gvoke And Nucala; A BTD For Tepotinib

The latest drug development news and highlights from our US FDA Performance Tracker. 

US FDA Performance Tracker Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mapp Biopharmaceutical Inc.
  • Senior Management
  • Larry Zeitlin, PhD, Pres.
  • Contact Info
  • Mapp Biopharmaceutical Inc.
    Phone: (858) 625-0335
    6160 Lusk Blvd.
    # C105
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register